fbpx

Interview with Jeannie Hill – SEO For Brand Owners – UPC Delayed – Important FCJ Decision Regarding Nullity Actions – 1000 Subscribers On YouTube Channel!!! – Episode 78 – IP Fridays

Jeanie Hill Subscribe: Apple Podcasts | Android | Email | Google Podcasts | Stitcher | TuneIn | RSS | More Interview with Jeannie Hill – SEO For Brand Owners – UPC Delayed – Important FCJ Decision Regarding Nullity Actions – 1000 Subscribers On My YouTube Channel!!! – Episode 78 – IP Fridays Rolf Claessen’s Youtube …

Interview with Jeannie Hill – SEO For Brand Owners – UPC Delayed – Important FCJ Decision Regarding Nullity Actions – 1000 Subscribers On YouTube Channel!!! – Episode 78 – IP Fridays Read More »

Interview with François Larose – New French Language Requirements in Canada For Trademark Owners – World IP Day Coming Up – Episode 77 – IP Fridays

François Larose Subscribe: Apple Podcasts | Android | Email | Google Podcasts | Stitcher | TuneIn | RSS | More Interview with François Larose – New French Language Requirements in Canada For Trademark Owners – World IP Day Coming Up – Episode 77 – IP Fridays Link to François Larose: http://www.bereskinparr.com/People/Francois-Larose Two links to more …

Interview with François Larose – New French Language Requirements in Canada For Trademark Owners – World IP Day Coming Up – Episode 77 – IP Fridays Read More »

ITC Section 337 Litigation

While Section 337 investigations at the U.S. International Trade Commission (ITC) are not known in common parlance, they are all too familiar to multinational corporations. The ITC has the power to order U.S. Customs and Border Protection to exclude the infringing articles from entry into the U.S., and may also issue a cease and desist …

ITC Section 337 Litigation Read More »

Abbreviated New Drug Application (ANDA) Litigation

In order for a generic drug pharmaceutical manufacturer to enter the market before the expiration of a patent covering an FDA-approved drug or method of treatment, it must file an Abbreviated New Drug Application (ANDA) and a Paragraph IV certification under the Hatch-Waxman Act. The certification alleges that the applicable patent listed in the FDA’s …

Abbreviated New Drug Application (ANDA) Litigation Read More »

People

Our counsel are leaders in the fields of intellectual property, business transactions and litigation.

Diversity

Enhancing Our Client Solutions At our firm we view diversity not as another corporate initiative, but as a vital component of how we conduct our business, and how our members live and work together. The diversity of our members, in race, culture, religion and belief systems fosters empathy and acceptance, creativity and innovation. We serve …

Diversity Read More »

Clients

Our legal services are offered to the leading corporations, governmental and quasi-governmental organizations, startup companies, research associations and technology creators the world over. With nearly two decades of experience per average lawyer, our counselors have represented leaders in their industries.

YouTube
LinkedIn
LinkedIn
Share